Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PMCB

PharmaCyte Biotech (PMCB)

PharmaCyte Biotech Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PMCB
FechaHoraFuenteTítuloSímboloCompañía
14/02/202414:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMCBPharmaCyte Biotech Inc
06/02/202408:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/12/202316:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMCBPharmaCyte Biotech Inc
28/11/202316:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
24/11/202315:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202316:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMCBPharmaCyte Biotech Inc
22/11/202315:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:PMCBPharmaCyte Biotech Inc
15/11/202307:30Business WirePharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc.NASDAQ:PMCBPharmaCyte Biotech Inc
31/10/202308:15Business WirePharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box TechnologyNASDAQ:PMCBPharmaCyte Biotech Inc
01/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PMCBPharmaCyte Biotech Inc
21/09/202316:04Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PMCBPharmaCyte Biotech Inc
15/09/202316:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202316:18Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PMCBPharmaCyte Biotech Inc
31/07/202315:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
19/07/202309:28Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PMCBPharmaCyte Biotech Inc
16/06/202316:23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202315:02Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:PMCBPharmaCyte Biotech Inc
15/06/202308:15Business WirePharmaCyte Biotech Announces Final Results of Tender OfferNASDAQ:PMCBPharmaCyte Biotech Inc
05/06/202315:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
25/05/202316:14Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PMCBPharmaCyte Biotech Inc
19/05/202316:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PMCBPharmaCyte Biotech Inc
11/05/202307:30Business WirePharmaCyte Biotech Announces Cash Tender Offer for up to 7,750,000 Shares at $3.25 Per ShareNASDAQ:PMCBPharmaCyte Biotech Inc
16/03/202315:43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PMCBPharmaCyte Biotech Inc
14/02/202315:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202308:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PMCBPharmaCyte Biotech Inc
02/02/202308:00Business WirePharmaCyte Biotech to Implement Second $10-Million Share Repurchase PlanNASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202215:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PMCBPharmaCyte Biotech Inc
30/12/202215:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PMCBPharmaCyte Biotech Inc
11/10/202203:45TipRanksH.C. Wainwright Keeps Their Hold Rating on PharmaCyte Biotech (PMCB)NASDAQ:PMCBPharmaCyte Biotech Inc
07/10/202208:00GlobeNewswire Inc.PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder ValueNASDAQ:PMCBPharmaCyte Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PMCB

Su Consulta Reciente

Delayed Upgrade Clock